92 biotech investors in the UK
We list 92 biotech investors in the UK as of November 2026: 2 have an SEC filing on file and 90 were checked on the firm's own website or an official register, and the list was last checked on 5 Nov 2026. The cities with the most head offices on this list are London (40), Cambridge (8) and Edinburgh (4).
Top 10 biotech investors in the UK, ranked by recent fund activity
Among firms with a published profile and a dated fund or deal in the last 24 months. The rule: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stated focus on the UK (15: full marks when the firm names the UK as where it invests, half when it says Europe or global), size of the fund on file on a log scale (15) and completeness of the public record (10). Regional focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns. The same rule orders the whole list; it is repeated in the method box.
BGF
Type: VC firm · HQ: United Kingdom · Stages: Seed, Series A, Series B, Growth · Focus: Biotech, Healthtech, Edtech, Developer Tools · Latest activity: Portfolio news, Oct 2026 · Fund size or assets: £3.0B (own site)
Portfolio news dated Oct 2026; £3.0B on file (own site); 20% of its observed portfolio is biotech and life sciences; names the UK as where it invests; 8 named decision-makers on file.
Start Codon
Type: Accelerator · HQ: Cambridge, United Kingdom · Stages: Pre-seed, Seed · Focus: Biotech, Healthtech, AI · Latest activity: Portfolio news, Nov 2026
Portfolio news dated Nov 2026; 53% of its observed portfolio is biotech and life sciences; names the UK as where it invests; 4 named decision-makers on file.
Cambridge Innovation Capital
Type: VC firm · HQ: Cambridge, United Kingdom · Stages: Seed, Series A, Growth · Focus: Biotech, Healthtech, AI, Fintech · Latest activity: New fund, Oct 2026 · Fund size or assets: £600M (own site)
Latest fund filing dated Oct 2026; £600M on file (own site); 53% of its observed portfolio is biotech and life sciences; 8 named decision-makers on file.
Epidarex Capital
Type: VC firm · HQ: Edinburgh, United Kingdom · Stages: Seed, Series A · Focus: Biotech, Healthtech, Medtech · Latest activity: Portfolio news, Jul 2026 · Private fund assets: $17M (SEC Form ADV)
Portfolio news dated Jul 2026; $17M on file (SEC Form ADV); 84% of its observed portfolio is biotech and life sciences; names the UK as where it invests; 8 named decision-makers on file.
Highland Europe
Type: VC firm · HQ: London, United Kingdom · Stages: Growth · Focus: Biotech, AI, Cybersecurity, SaaS · Latest activity: New fund, Jul 2026 · Fund size or assets: €1.1B (own site)
Latest fund filing dated Jul 2026; €1.1B on file (own site); 29% of its observed portfolio is biotech and life sciences; names the UK as where it invests; 8 named decision-makers on file.
Claret Capital Partners
Type: Venture debt · HQ: London, United Kingdom · Stages: Series B, Growth, Late stage · Focus: Biotech, Healthtech, Climate Tech, SaaS · Latest activity: New deal, Oct 2026 · Fund size or assets: €575M (own site)
Dated new deal in Oct 2026; €575M on file (own site); states biotech and life sciences as a focus; 8 named decision-makers on file.
Archangels
Type: Angel network · HQ: Edinburgh, United Kingdom · Stages: Pre-seed, Seed, Series A, Growth · Focus: Biotech, Media, Deep Tech, Healthtech · Latest activity: Portfolio news, Nov 2026 · Fund size or assets: £10M (own site)
Portfolio news dated Nov 2026; £10M on file (own site); states biotech and life sciences as a focus; names the UK as where it invests; 8 named decision-makers on file.
LYVA Labs
Type: Government or university fund · HQ: Liverpool, United Kingdom · Stages: Pre-seed · Focus: Biotech, AI, Healthtech, Climate Tech · Latest activity: Portfolio news, Oct 2026 · Fund size or assets: £7M (own site)
Portfolio news dated Oct 2026; £7M on file (own site); states biotech and life sciences as a focus; names the UK as where it invests; 8 named decision-makers on file.
Cambridge Capital Group
Type: Angel network · HQ: Cambridge, United Kingdom · Stages: Seed, Growth · Focus: Biotech, Industrial Tech, AI, Developer Tools · Latest activity: New fund, Oct 2026 · Fund size or assets: £50M (own site)
Latest fund filing dated Oct 2026; £50M on file (own site); 16% of its observed portfolio is biotech and life sciences; names the UK as where it invests; 2 named decision-makers on file.
Outlier Ventures
Type: VC firm · HQ: United Kingdom · Stages: Pre-seed, Seed, Series A, Growth · Focus: Biotech, AI, Robotics, Fintech · Latest activity: New deal, Oct 2026 · Fund size or assets: $500M (own site)
Dated new deal in Oct 2026; $500M on file (own site); states biotech and life sciences as a focus.
First 25 of 92 biotech investors in the UK
| Investor | Type | HQ | Stagesour research | Focusour research | Latest fund or deal | Fund sizeas filed or stated | Checked | Contacts |
|---|---|---|---|---|---|---|---|---|
| BGF | VC firm | United Kingdom | Seed, Series A, Series B, Growth | Biotech, Healthtech, Edtech, Developer Tools | Portfolio news, Oct 2026 | £3.0B (own site) | 4 Nov 2026 | 8 names · Unlock |
| Start Codon | Accelerator | Cambridge, United Kingdom | Pre-seed, Seed | Biotech, Healthtech, AI | Portfolio news, Nov 2026 | 4 Nov 2026 | 4 names, firm email · Unlock | |
| Cambridge Innovation Capital | VC firm | Cambridge, United Kingdom | Seed, Series A, Growth | Biotech, Healthtech, AI, Fintech | New fund, Oct 2026 | £600M (own site) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Epidarex Capital | VC firm | Edinburgh, United Kingdom | Seed, Series A | Biotech, Healthtech, Medtech | Portfolio news, Jul 2026 | $17M (SEC Form ADV) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Highland Europe | VC firm | London, United Kingdom | Growth | Biotech, AI, Cybersecurity, SaaS | New fund, Jul 2026 | €1.1B (own site) | 4 Nov 2026 | 8 names · Unlock |
| Claret Capital Partners | Venture debt | London, United Kingdom | Series B, Growth, Late stage | Biotech, Healthtech, Climate Tech, SaaS | New deal, Oct 2026 | €575M (own site) | 4 Nov 2026 | 8 names · Unlock |
| Archangels | Angel network | Edinburgh, United Kingdom | Pre-seed, Seed, Series A, Growth | Biotech, Media, Deep Tech, Healthtech | Portfolio news, Nov 2026 | £10M (own site) | 4 Nov 2026 | 8 names, firm email · Unlock |
| LYVA Labs | Government or university fund | Liverpool, United Kingdom | Pre-seed | Biotech, AI, Healthtech, Climate Tech | Portfolio news, Oct 2026 | £7M (own site) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Cambridge Capital Group | Angel network | Cambridge, United Kingdom | Seed, Growth | Biotech, Industrial Tech, AI, Developer Tools | New fund, Oct 2026 | £50M (own site) | 4 Nov 2026 | 2 names · Unlock |
| Outlier Ventures | VC firm | United Kingdom | Pre-seed, Seed, Series A, Growth | Biotech, AI, Robotics, Fintech | New deal, Oct 2026 | $500M (own site) | 4 Nov 2026 | LinkedIn page · Unlock |
| Gabriel Investment Syndicate | Angel network | United Kingdom | Pre-seed, Seed | Biotech, Healthtech, Generalist, Deep Tech | Portfolio news, Oct 2026 | £4M (own site) | 4 Nov 2026 | 4 names, firm email · Unlock |
| Equity Gap | Angel network | Edinburgh, United Kingdom | Seed | Biotech, Healthtech, Climate Tech, SaaS | Portfolio news, Jul 2026 | £70M (own site) | 4 Nov 2026 | 4 names, firm email · Unlock |
| Empirical Ventures | SEIS/EIS fund | London, United Kingdom | Pre-seed, Seed | Biotech, Energy, Semiconductor, Deep Tech | New deal, Jul 2026 | £50M (own site) | 4 Nov 2026 | 6 names, firm email · Unlock |
| Cambridge Angels | Angel network | Cambridge, United Kingdom | Seed | Biotech, Healthtech, Deep Tech, AI | Portfolio news, Oct 2026 | £400M (own site) | 4 Nov 2026 | LinkedIn page · Unlock |
| UKI2S | VC firm | London, United Kingdom | Pre-seed, Seed | Biotech, Healthtech, AI, Deep Tech | New deal, Jul 2025 | £150M (own site) | 4 Nov 2026 | 8 names · Unlock |
| Kelvin Capital | Angel network | Glasgow, United Kingdom | Seed, Growth | Biotech, Generalist, Agritech, Climate Tech | New fund, Mar 2026 | £150M (own site) | 4 Nov 2026 | 6 names, firm email · Unlock |
| Advent Life Sciences | VC firm | London, United Kingdom | Seed, Series A, Series B, Growth | Biotech, Healthtech | New fund, May 2026 | 4 Nov 2026 | 8 names, firm email · Unlock | |
| Martlet Capital | VC firm | Cambridge, United Kingdom | Pre-seed, Seed | Biotech, Healthtech, AI, Deep Tech | New deal, Jun 2026 | 4 Nov 2026 | 4 names, firm email · Unlock | |
| Eos Advisory | Angel network | St Andrews, United Kingdom | Seed, Series A, Growth | Biotech, Healthtech, Robotics, AI | Portfolio news, Mar 2026 | 4 Nov 2026 | 7 names, firm email · Unlock | |
| Catapult Ventures | Fund manager | Spalding, United Kingdom | Seed, Growth | Biotech, AI, Robotics, Fintech | Portfolio news, Apr 2026 | $80M (SEC Form D, 2026) | 4 Nov 2026 | 5 names, firm email · Unlock |
| Elbow Beach | VC firm | London, United Kingdom | Pre-seed, Seed | Biotech, Energy, Climate Tech, Agritech | New deal, Oct 2026 | 4 Nov 2026 | 8 names, firm email · Unlock | |
| o2h Ventures | SEIS/EIS fund | Cambridge, United Kingdom | Seed, Growth | Biotech, Healthtech, AI, Deep Tech | New deal, Nov 2025 | £8M (own site) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Calculus Capital | SEIS/EIS fund | London, United Kingdom | Growth | Biotech, Fintech, SaaS, Healthtech | Portfolio news, Jun 2026 | 4 Nov 2026 | 8 names, firm email · Unlock | |
| Cambridge Enterprise | Government or university fund | Cambridge, United Kingdom | Biotech, AI, Industrial Tech, Deep Tech | Portfolio news, Oct 2026 | 4 Nov 2026 | 8 names · Unlock | ||
| Oxford Science Enterprises | VC firm | Oxford, United Kingdom | Pre-seed, Seed, Series A, Series B, Growth | Biotech, Healthtech, AI, Deep Tech | Portfolio news, Mar 2026 | £1.4B (own site) | 4 Nov 2026 | 8 names, firm email · Unlock |
You are seeing 25 of 92. The full list adds 67 more investors and 494 named decision-makers.
One-time payment. No subscription. No account.
Or get the free sample.
How these 92 break down
By city
| City | On this list | Share |
|---|---|---|
| London | 40 | 43% |
| Cambridge | 8 | 9% |
| Edinburgh | 4 | 4% |
| Oxford | 4 | 4% |
| Bristol | 3 | 3% |
| Belfast | 2 | 2% |
| Manchester | 2 | 2% |
Full lists, each with its own row count: Biotech investors in London (42)
By stage
| Stage | On this list | Share |
|---|---|---|
| Pre-Seed | 41 | 45% |
| Seed | 75 | 82% |
| Series A | 38 | 41% |
| Series B | 15 | 16% |
| Growth | 34 | 37% |
Stage is our research. A firm can back more than one stage.
By type
| Type | On this list | Share |
|---|---|---|
| VC firm | 41 | 45% |
| Angel network | 18 | 20% |
| SEIS/EIS fund | 9 | 10% |
| Government or university fund | 8 | 9% |
| Fund manager | 5 | 5% |
| Accelerator | 4 | 4% |
Method and limits
- Source
- 2 of the 92 rows carry an SEC filing (Form D or Form ADV). All 92 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule
- Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states biotech and life sciences as a focus on its own site, or we observed it in the firm's portfolio.
- Order
- Firms with a published profile come first. Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stated focus on the UK (15: full marks when the firm names the UK as where it invests, half when it says Europe or global), size of the fund on file on a log scale (15) and completeness of the public record (10). Regional focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Last refreshed
- November 2026. Rows on this list were checked between 4 Nov 2026 and 5 Nov 2026.
- Fill rates
- Of 92 rows: stage 88, sector 92, fund size 33, website 92. In the paid file: named decision-makers on 81 rows, firm email on 62, LinkedIn page on 73, check size on 46.
- Corrections
- Email [email protected] or use the update form. We act within 5 working days.
Questions
How many biotech investors in the UK are there?
We list 92 as of November 2026. 38 of the 92 have a fund filing or a dated deal in the last 12 months. The cities with the most are London (40), Cambridge (8) and Edinburgh (4).
Which biotech investors in the UK raised a new fund in the last 12 months?
3 of the 92 have a fund filing dated in the last 12 months. The most recent on this list are Highland Europe (Jul 2026), ET Capital (Apr 2026) and Medicxi (Nov 2025).
What is the typical fund size of biotech investors in the UK?
Too few firms on this list disclose a fund size on an SEC Form D to give a median (1 of 92). 32 rows carry a size or assets figure from another public source, for example BGF at £3.0B (own site) and Cambridge Innovation Capital at £600M (own site).
Which stage do most biotech investors in the UK back?
Of the 88 with a stage on file, seed (75), pre-seed (41) and Series A (38). A firm can back more than one stage, and 4 rows have no stage on file yet.
Where does the data on biotech investors in the UK come from and how often is it updated?
2 of the 92 rows have an SEC filing on file (Form D or Form ADV) and 90 were checked on the firm's own website or an official register. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 5 Nov 2026 at the latest. The whole file is re-verified twice a year.
Can I download the list of biotech investors in the UK as a spreadsheet?
Yes. The file holds all 92 rows in Excel and CSV, with 494 named decision-makers and 62 firm emails, for $49 one-time. 25 rows are free on this page.
Narrower lists
Related lists
CPG investors in the UK (29)Consumer investors in the UK (89)Edtech investors in the UK (33)Proptech investors in the UK (23)Climate tech investors in the UK (146)Deep tech investors in the UK (135)Hardware investors in the UK (41)Impact investors in the UK (22)Food and beverage investors in the UK (19)Biotech venture capital firms in the US (297)SaaS investors in the UK (223)AI investors in the UK (214)Healthtech investors in the UK (194)Fintech investors in the UK (165)Biotech investors in Europe (89)B2B investors in the UK (73)Energy investors in the UK (63)Medtech investors in the UK (58)
Not sure this is the right list? Describe your raise in the investor matching tool and get a shortlist. The link opens it set to biotech and life sciences and the UK. Guide: how to build an investor list. Markdown version of this page.
Check the quality first
A free sample of 100 investors, every column, with sources and dates.